Correlation Between Kulicke and Entero Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Kulicke and Entero Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kulicke and Entero Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kulicke and Soffa and Entero Therapeutics,, you can compare the effects of market volatilities on Kulicke and Entero Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kulicke with a short position of Entero Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kulicke and Entero Therapeutics,.
Diversification Opportunities for Kulicke and Entero Therapeutics,
0.47 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Kulicke and Entero is 0.47. Overlapping area represents the amount of risk that can be diversified away by holding Kulicke and Soffa and Entero Therapeutics, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Entero Therapeutics, and Kulicke is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kulicke and Soffa are associated (or correlated) with Entero Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Entero Therapeutics, has no effect on the direction of Kulicke i.e., Kulicke and Entero Therapeutics, go up and down completely randomly.
Pair Corralation between Kulicke and Entero Therapeutics,
Given the investment horizon of 90 days Kulicke and Soffa is expected to generate 0.37 times more return on investment than Entero Therapeutics,. However, Kulicke and Soffa is 2.71 times less risky than Entero Therapeutics,. It trades about 0.14 of its potential returns per unit of risk. Entero Therapeutics, is currently generating about -0.28 per unit of risk. If you would invest 4,558 in Kulicke and Soffa on September 2, 2024 and sell it today you would earn a total of 284.00 from holding Kulicke and Soffa or generate 6.23% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Kulicke and Soffa vs. Entero Therapeutics,
Performance |
| Timeline |
| Kulicke and Soffa |
| Entero Therapeutics, |
Kulicke and Entero Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Kulicke and Entero Therapeutics,
The main advantage of trading using opposite Kulicke and Entero Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kulicke position performs unexpectedly, Entero Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Entero Therapeutics, will offset losses from the drop in Entero Therapeutics,'s long position.| Kulicke vs. Ultra Clean Holdings | Kulicke vs. Ichor Holdings | Kulicke vs. Entegris | Kulicke vs. Amtech Systems |
| Entero Therapeutics, vs. Tff Pharmaceuticals | Entero Therapeutics, vs. Eliem Therapeutics | Entero Therapeutics, vs. Inhibrx | Entero Therapeutics, vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Complementary Tools
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Stocks Directory Find actively traded stocks across global markets | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |